SCHEMBL801039

SCHEMBL801039

CN(C)CCC(O)C1(c2nc(-c3nc(C(=O)OC(C)(C)C)co3)co2)SCCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10045777 0.73
SCHEMBL800770 0.70 HPGDS (0.30)
SCHEMBL800497 0.65
SCHEMBL800885 0.64 C3AR1 (0.31)
SCHEMBL12452875 0.64 C3AR1 (0.30)
SCHEMBL12299190 0.63 GPR119 (0.34)
SCHEMBL800887 0.61
SCHEMBL12452865 0.60 HDAC1 (0.34)
SCHEMBL30424999 0.58 ALDH1A1 (0.59)
SCHEMBL800773 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518928-B2 Therapeutic compounds RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2013-08-27 US disclosed
US-20120071527-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-22 US disclosed